Skip to main content
Signal8

Fair Richard A.

SEC insider (Form 3/4/5 filer). CIK 0001695851. PRESIDENT AND CEO at Enliven Therapeutics, Inc. (ELVN). 1 reported Form 4/5 transaction since Sep 2024; latest on Dec 11, 2025. Located in BOULDER, CO.

Companies Fair Richard A. has filed insider reports for

  • Enliven Therapeutics, Inc. (ELVN): Director, Officer, PRESIDENT AND CEO
Fair Richard A. profile photo

Fair Richard A.

CIK: 0001695851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Enliven Therapeutics, Inc. logo
ELVN

Enliven Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Enliven Therapeutics, Inc. logo
    ELVN

    Enliven Therapeutics, Inc.

    Dec 11, 2025
    Award

    Stock Option (right to buy)

    Direct
    875K shares-

1-1 of 1